Search
for
Sort by
Research 571–600 of 1000+
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- A Case Report of Cushing’s Disease Presenting as Hair Loss
- Endocrine evaluation of hirsutism
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Updates on Hirsutism: A Narrative Review
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- A clinical study of pemphigus vulgaris and its variants, evaluation of safety and efficacy of glucocorticoids versus immunosuppressants at tertiary care hospital: a study of 75 cases
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- Association of Cyp11a Gene with Polycystic Ovarian Syndrome Patients in Lahore, Pakistan
- If Women Just had Their Hormones Back the Way they Were!
- Polycystic Ovary Syndrome Is a Challenging Problem in Women
- If women just had their hormones back the way they were! (for youthful feeling-balance your hormones!)
- Acne Vulgaris
- Mucocutaneous Manifestations of Endocrine Disorders
- The childbearing years: hair diseases
- Analysis of Female Pattern Hair loss
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Association of Risk Factors with Female Pattern Hair Loss
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism